Gut Liver.
2022 Jul;16(4):503-514. 10.5009/gnl210224.
Management of Helicobacter pylori Infection: A Comparison between Korea and the United States
- Affiliations
-
- 1Division of Gastroenterology and Hepatology, Stanford University, Stanford, CA, USA
- 2Division of Gastroenterology, Department of Internal Medicine, Kosin University College of Medicine, Busan, Korea
- KMID: 2531233
- DOI: http://doi.org/10.5009/gnl210224
Abstract
- Helicobacter pylori has been well known to cause gastritis, peptic ulcers, mucosa-associated lymphoid tissue, and gastric cancer. The importance of H. pylori eradication has been emphasized; however, the management of H. pylori infection is difficult in clinical practice. In both Eastern and Western countries, there has been a constant interest in confirming individuals who should be tested and treated for H. pylori infection and developing methods to diagnose H. pylori infection. Many studies have been implemented to successfully eradicate H. pylori, and various combinations of eradication regimens for H. pylori infection have been suggested worldwide. Based on the findings of previous studies, a few countries have published their own guidelines that are appropriate for their country; however, these country-specific guidelines may differ depending on the circumstances in each country. Evidence-based guidelines and clinical practice updates for the treatment of H. pylori infection have been published in Korea and the United States in 2021. This review will summarize the similarities and differences in the management of H. pylori infection in Korea and the United States, focusing on indications, diagnosis, and treatments based on recent guidelines and recommendations in both countries.
